<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="168219">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01976299</url>
  </required_header>
  <id_info>
    <org_study_id>TP-6364</org_study_id>
    <nct_id>NCT01976299</nct_id>
  </id_info>
  <brief_title>AVERT™ Clinical Trial</brief_title>
  <acronym>AVERT™</acronym>
  <official_title>AVERT™ Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Osprey Medical, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Osprey Medical, Inc</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>Germany: Federal Institute for Drugs and Medical Devices (BfArM)</authority>
    <authority>Australia: Therapeutic Goods Administration (TGA)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to assess the AVERT System device, which is designed to limit
      the volume of CM (Contrast Media) utilized, during a staged therapeutic coronary PCI
      (Percutaneous Coronary Intervention) or a coronary diagnostic procedure that is anticipated
      to become a PCI (i.e. ad hoc PCI) for the reduction of CIN (Contrast Induced Nephropathy).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Primary Effectiveness Endpoint</measure>
    <time_frame>3 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Reduction in the incidence of Contrast Induced Nephropathy (CIN)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Safety Endpoint</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Incidence of device related serious adverse events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoint 1</measure>
    <time_frame>30 Days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Reduction in volume contrast media required</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoint 2</measure>
    <time_frame>30 Days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Comparing event rates of major adverse events.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoint 3</measure>
    <time_frame>3 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in kidney function.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Contrast Induced Nephropathy (CIN)</condition>
  <arm_group>
    <arm_group_label>Active Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard of Care with the AVERT system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AVERT</intervention_name>
    <arm_group_label>Active Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The subject is a candidate for a therapeutic percutaneous coronary intervention (PCI)
             procedure.

          -  The subject has documented chronic kidney disease (CKD)

        Exclusion Criteria:

          -  Subject is in acute renal failure

          -  Assessment of ventricular function that cannot be accomplished without the use of the
             CM.

          -  Subject has acute STEMI within 72 hours prior to planned PCI procedure, or is
             currently having an acute STEMI.

          -  Subject is unable to undergo peri-procedural hydration.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Joshua Carlson</last_name>
    <phone>952-955-8248</phone>
    <email>jcarlson@ospreymed.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Luke's Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renata Schwartz, MBA, RN, BSN</last_name>
      <phone>602-251-8890</phone>
      <email>rschwartz@iasishealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Richard Heuser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Brown</last_name>
      <phone>626-564-7845</phone>
      <email>cynthia.a.brown@kp.org</email>
    </contact>
    <investigator>
      <last_name>Somjot Brar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford Hospital and Clinics</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305-5218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Homa Tavana</last_name>
      <phone>650-721-5540</phone>
      <email>htavana@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>David P. Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harbor UCLA Medical Center</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90509</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elaine Santana-Fernandes</last_name>
      <phone>310-781-3634</phone>
      <email>esantana@labiomed.org</email>
    </contact>
    <investigator>
      <last_name>Joseph Thomas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Heart &amp; Vascular Institute of Florida</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Duncan</last_name>
      <phone>727-489-2552</phone>
      <email>wduncan@HAVI-North.com</email>
    </contact>
    <investigator>
      <last_name>Patrick A. Cambier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tallahassee Research Institute, Inc.</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patty Knap, RN, CCRC</last_name>
      <phone>850-431-5024</phone>
      <email>patty.knap@tmh.org</email>
    </contact>
    <investigator>
      <last_name>Wayne Batchelor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital (Emory)</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Ellis-Bailey, RN, BSN</last_name>
      <phone>678-843-6052</phone>
      <email>cindy.bailey@emoryhealthcare.org</email>
    </contact>
    <investigator>
      <last_name>George Chang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. John Hospital and Medical Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Jacobson</last_name>
      <phone>313-343-3568</phone>
      <email>teresa.jacobson@stjohn.org</email>
    </contact>
    <investigator>
      <last_name>Thomas P. Davis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lindsey Seifert</last_name>
      <phone>816-932-9862</phone>
      <email>lseifert@saint-lukes.org</email>
    </contact>
    <investigator>
      <last_name>Anthony Hart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bonnie Miller</last_name>
      <phone>405-608-4758</phone>
      <email>bmiller@okheart.com</email>
    </contact>
    <investigator>
      <last_name>Thomas McGarry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joe Carothers</last_name>
      <phone>412-359-4156</phone>
      <email>jcarothe@wpahs.org</email>
    </contact>
    <investigator>
      <last_name>David M. Lasorda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>York Hospital</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Delio-Cox, RN, MSN, CCRC</last_name>
      <phone>717.851.3472</phone>
      <email>bdeliocox@wellspan.org</email>
    </contact>
    <investigator>
      <last_name>Paul Tolerico, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Providence Cardiology LLC</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marty Davids, RN, BSN</last_name>
      <phone>803-255-2927</phone>
      <email>mdavids@scheart.com</email>
    </contact>
    <investigator>
      <last_name>Patrick A. Hall, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baptist Memorial Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Albritton, RN</last_name>
      <phone>901-226-1688</phone>
      <email>cynthia.albritton@bmhcc.org</email>
    </contact>
    <investigator>
      <last_name>David Wolford, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lenis Sosa, BSRN</last_name>
      <phone>713-441-3245</phone>
      <email>lsosa@houstonmethodist.org</email>
    </contact>
    <investigator>
      <last_name>Alpesh Shad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>U of TX Health Science Center San Antonio (UTHSCSA)</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229-3900</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irma Scholler, RN, MSN</last_name>
      <phone>210-567-8539</phone>
      <email>scholler@uthscsa.edu</email>
    </contact>
    <investigator>
      <last_name>Arnand Prasad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Trinity Mother Frances/Cardiovascular Associates of East Texas PA</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pamela Dicamillo, LVN, CCRC</last_name>
      <phone>903-595-2283</phone>
      <phone_ext>2103</phone_ext>
      <email>pdicamillo@caet.net</email>
    </contact>
    <investigator>
      <last_name>Jeffrey G. Carr, MD, FACC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Cardiovascular Research Institute / Norfolk General</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melinda Bullivant, RN</last_name>
      <phone>757-388-4024</phone>
      <email>mmbulliv@sentara.com</email>
    </contact>
    <investigator>
      <last_name>Paul D. Mahoney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heart Center Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vivian Mak</last_name>
      <phone>03-9076-2948</phone>
      <email>v.mak@alfred.oprg.au</email>
    </contact>
    <investigator>
      <last_name>David Kaye, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Australia</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 19, 2014</lastchanged_date>
  <firstreceived_date>October 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
